date,title,source
Nov-09-18,Soligenix Announces Recent Accomplishments And Third Quarter 2018 Financial Results,PR Newswire
Nov-14-18,"Investor Expectations to Drive Momentum within GEE Group, GigaMedia, China XD Plastics Company, Soligenix, Energy Transfer LP, and Oil-Dri Corporation Of America  Discovering Underlying Factors of Influence",GlobeNewswire
Nov-19-18,SNGX: Two Phase 3 Data Readouts Over Next 12-15 Months,Zacks Small Cap Research
Dec-11-18,"The Daily Biotech Pulse: Management Change At Merck, Jazz Buyback, Arrowhead Earnings",Benzinga
Dec-11-18,"Soligenix to Receive $611,000 in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program",PR Newswire
Jan-23-19,Soligenix Receives European Patent for Dusquetide and Related Innate Defense Regulator Analogs,PR Newswire
Feb-07-19,Soligenix Announces Publication Demonstrating Thermostabilization of an Ebola Subunit Vaccine Candidate,PR Newswire
Feb-12-19,SNGX: Innate Defense Regulators Offer New Approach to Treating Infections,Zacks Small Cap Research
Mar-11-19,Soligenix to Present at the Boston Oncology Investor Conference 2019,PR Newswire
Mar-26-19,Soligenix Announces Recent Accomplishments and Year-End 2018 Financial Results,PR Newswire
Mar-29-19,SNGX: Interim Analysis of SGX942 in Oral Mucositis in Third Quarter of 2019,Zacks Small Cap Research
Apr-04-19,Soligenix Receives US Patent for Dusquetide Related Analogs,PR Newswire
Apr-09-19,Soligenix and the European Medicines Agency Pediatric Committee Reach Agreement on the Pediatric Investigation Plan for SGX942,PR Newswire
Apr-15-19,"Soligenix Receives $611,000 in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program",PR Newswire
